PharmaBoardroom

Technology Convergence in the Digital Era: What Implications for…

Pierre Meulien of the Innovative Medicines Initiative (IMI) discusses the potential impact that new technological innovations will have on the drug…

East vs West: Bridging the Access Gap in European Cancer Care

From her vantage point as associate vice president for MSD's Central & Eastern Europe (CEE) cluster, Gabriele Grom outlines the disparity that…

AI & Blockchain: The Time for Pharma to Invest is Now

Axel Schumacher highlights the vital importance of AI and blockchain for the future success of pharmaceutical companies, the significant knowledge gap…

Taming the ‘Wild West’ of CBD

Monica Weldon looks at the history of medicinal CBD, its current usages in the USA, and why robust scientific research on its efficacy need to be…

Scaling Healthcare’s Digital Transformation with AI

Digital marketing expert Buck Dossey expounds the importance of soliciting user data to improve patient experiences and the ways in which AI can be…

Change is Coming for Healthcare

Aditya Bhattacharji examines whether current healthcare models are truly fit for purpose and how healthcare is becoming a more politicised issue…

Comprehensive Access to Medicines should be the Priority for…

Canada is the only developed country with a universal healthcare system that does not provide universal coverage of prescription drugs. With a new…

The Medical Cannabis Investment Landscape

David H. Crean, managing director for Objective Capital Partners, highlights the progress that has been made over the past year in investments in…

Is CNS the Next Oncology?

Cerecin's Charles Stacey looks at the large unmet medical need in diseases of the central nervous system (CNS), the looming socioeconomic burden that…